NYSE:PEN - Penumbra Stock Price, Price Target & More

$124.75 -0.45 (-0.36 %)
(As of 04/20/2018 04:00 PM ET)
Previous Close$124.75
Today's Range$124.40 - $126.6750
52-Week Range$77.75 - $127.40
Volume146,777 shs
Average Volume267,080 shs
Market Capitalization$4.27 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.01

About Penumbra (NYSE:PEN)

Penumbra logoPenumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, Japan, and internationally. The company offers neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, DDC, and PX SLIM brands; aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the ACE and the 3D Revascularization Device brands. It also offers neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400 and Penumbra SMART Coil brands. In addition, the company provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; and detachable embolic coil systems for peripheral embolization under the RUBY Coil brand, as well as microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand. Further, it offers detachable, microcatheter-deliverable occlusion devices designed primarily to occlude peripheral vessels under the POD (Penumbra Occlusion Device) brand; and aspiration-based thrombectomy systems for peripheral applications under the Indigo System brand, as well as a complementary device for use with RUBY Coil and POD for vessel occlusion under the POD Packing Coil brand. The company sells its products through direct sales organizations and distributors to hospitals in neuro and peripheral vascular markets. Penumbra, Inc. was founded in 2004 and is headquartered in Alameda, California.

Receive PEN News and Ratings via Email

Sign-up to receive the latest news and ratings for PEN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
SymbolNYSE:PEN
CUSIPN/A
Phone510-748-3200

Debt

Debt-to-Equity RatioN/A
Current Ratio7.41%
Quick Ratio5.57%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E Ratio891.07
P/E Growth45.53

Sales & Book Value

Annual Sales$333.76 million
Price / Sales12.76
Cash Flow$0.1225 per share
Price / Cash1,018.73
Book Value$11.80 per share
Price / Book10.57

Profitability

EPS (Most Recent Fiscal Year)($0.01)
Net Income$4.65 million
Net Margins1.40%
Return on Equity-0.23%
Return on Assets-0.20%

Miscellaneous

Employees1,700
Outstanding Shares34,130,000

How to Become a New Pot Stock Millionaire

Penumbra (NYSE:PEN) Frequently Asked Questions

What is Penumbra's stock symbol?

Penumbra trades on the New York Stock Exchange (NYSE) under the ticker symbol "PEN."

How were Penumbra's earnings last quarter?

Penumbra (NYSE:PEN) issued its quarterly earnings data on Tuesday, February, 27th. The company reported $0.10 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.01) by $0.11. The firm earned $96.05 million during the quarter, compared to analysts' expectations of $87.69 million. Penumbra had a net margin of 1.40% and a negative return on equity of 0.23%. View Penumbra's Earnings History.

What price target have analysts set for PEN?

6 Wall Street analysts have issued 12-month target prices for Penumbra's stock. Their predictions range from $115.00 to $145.00. On average, they expect Penumbra's stock price to reach $130.75 in the next twelve months. View Analyst Ratings for Penumbra.

What are Wall Street analysts saying about Penumbra stock?

Here are some recent quotes from research analysts about Penumbra stock:
  • 1. Canaccord Genuity analysts commented, "We would stay buyers of PEN, which continues to be a top pick in S/Mid-cap med-tech. We picked up notable legislative progress out of Tennessee both noteworthy and positive for PEN as well as the AIS market in general." (4/5/2018)
  • 2. According to Zacks Investment Research, "Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. " (1/17/2018)

Who are some of Penumbra's key competitors?

Who are Penumbra's key executives?

Penumbra's management team includes the folowing people:
  • Mr. Adam Elsesser, Co Founder, Chairman, Chief Exec. Officer and Pres (Age 56)
  • Dr. Arani Bose M.D., Co-Founder, Chief Innovator and Director (Age 56)
  • Mr. Sridhar N. Kosaraju, Chief Financial Officer and Head of Strategy (Age 40)
  • Ms. Lynn Rothman, Chief Bus. Officer and Exec. VP (Age 57)
  • Mr. Daniel Donen Davis, Chief Commercial Officer & Pres of North America (Age 40)

Has Penumbra been receiving favorable news coverage?

News headlines about PEN stock have been trending positive recently, Accern reports. Accern identifies negative and positive media coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Penumbra earned a news sentiment score of 0.36 on Accern's scale. They also assigned press coverage about the company an impact score of 45.67 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.

How do I buy shares of Penumbra?

Shares of PEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Penumbra's stock price today?

One share of PEN stock can currently be purchased for approximately $124.75.

How big of a company is Penumbra?

Penumbra has a market capitalization of $4.27 billion and generates $333.76 million in revenue each year. The company earns $4.65 million in net income (profit) each year or ($0.01) on an earnings per share basis. Penumbra employs 1,700 workers across the globe.

How can I contact Penumbra?

Penumbra's mailing address is One Penumbra Place, Alameda CA, 94502. The company can be reached via phone at 510-748-3200 or via email at [email protected]


MarketBeat Community Rating for Penumbra (PEN)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  155 (Vote Outperform)
Underperform Votes:  88 (Vote Underperform)
Total Votes:  243
MarketBeat's community ratings are surveys of what our community members think about Penumbra and other stocks. Vote "Outperform" if you believe PEN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PEN will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Penumbra (NYSE:PEN) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
6 Wall Street analysts have issued ratings and price targets for Penumbra in the last 12 months. Their average twelve-month price target is $130.75, suggesting that the stock has a possible upside of 4.81%. The high price target for PEN is $145.00 and the low price target for PEN is $115.00. There are currently 2 hold ratings and 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyHoldBuy
Consensus Rating Score: 2.672.602.333.00
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $130.75$126.00$111.50$98.00
Price Target Upside: 4.81% upside4.05% upside18.49% upside6.99% upside

Penumbra (NYSE:PEN) Consensus Price Target History

Price Target History for Penumbra (NYSE:PEN)

Penumbra (NYSE:PEN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/5/2018Canaccord GenuityReiterated RatingBuy$125.00LowView Rating Details
4/4/2018Goldman SachsInitiated CoverageBuy$145.00HighView Rating Details
3/13/2018Wells FargoBoost Price TargetReduce -> Outperform$138.00MediumView Rating Details
2/28/2018BMO Capital MarketsBoost Price TargetMarket Perform -> Market Perform$110.00 -> $115.00LowView Rating Details
2/21/2018William BlairInitiated CoverageOutperform -> OutperformLowView Rating Details
1/2/2018JPMorgan ChaseDowngradeOverweight -> NeutralHighView Rating Details
(Data available from 4/21/2016 forward)

Earnings

Penumbra (NYSE:PEN) Earnings History and Estimates Chart

Earnings by Quarter for Penumbra (NYSE:PEN)

Penumbra (NYSE:PEN) Earnings Estimates

2018 EPS Consensus Estimate: $0.10
2019 EPS Consensus Estimate: $0.32
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181($0.02)($0.02)($0.02)
Q2 20181$0.01$0.01$0.01
Q3 20181$0.04$0.04$0.04
Q4 20181$0.07$0.07$0.07
Q1 20191$0.06$0.06$0.06
Q2 20191$0.08$0.08$0.08
Q3 20191$0.06$0.06$0.06
Q4 20191$0.12$0.12$0.12

Penumbra (NYSE PEN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/27/2018Q4 2017($0.01)$0.10$87.69 million$96.05 millionViewN/AView Earnings Details
11/7/2017Q3 2017($0.0580)$0.0070$79.17 million$83.90 millionViewN/AView Earnings Details
8/8/2017Q2 2017($0.05)($0.05)$77.16 million$80.60 millionViewListenView Earnings Details
5/9/2017Q1 2017($0.06)($0.10)$71.08 million$73.21 millionViewListenView Earnings Details
2/28/2017Q416($0.09)($0.08)$67.54 million$73.10 millionViewListenView Earnings Details
11/3/2016Q316($0.08)($0.04)$63.25 million$67.20 millionViewN/AView Earnings Details
8/9/2016Q216($0.07)$0.01$58.18 million$65.10 millionViewN/AView Earnings Details
5/9/2016Q116($0.07)$0.02$53.10 million$57.90 millionViewN/AView Earnings Details
3/8/2016Q415($0.10)$0.05$46.76 million$54.40 millionViewN/AView Earnings Details
11/12/2015Q315($0.15)$0.03$43.00 million$50.42 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Penumbra (NYSE:PEN) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Penumbra (NYSE PEN) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 13.50%
Institutional Ownership Percentage: 73.42%
Insider Trading History for Penumbra (NYSE:PEN)
Institutional Ownership by Quarter for Penumbra (NYSE:PEN)

Penumbra (NYSE PEN) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/15/2018Lynn RothmanEVPSell6,000$125.02$750,120.00144,319View SEC Filing  
3/12/2018Robert D EvansEVPSell10,000$121.03$1,210,300.0012,225View SEC Filing  
3/6/2018Lynn RothmanEVPSell3,727$115.01$428,642.27153,155View SEC Filing  
2/28/2018Lynn RothmanEVPSell2,273$115.00$261,395.00154,046View SEC Filing  
1/29/2018Don W KassingDirectorSell2,000$100.94$201,880.002,648View SEC Filing  
1/16/2018Daniel Donen DavisInsiderSell30,000$88.80$2,664,000.00View SEC Filing  
1/16/2018Lynn RothmanEVPSell6,000$90.99$545,940.00159,519View SEC Filing  
1/2/2018Robert D EvansEVPSell40,000$89.89$3,595,600.0011,704View SEC Filing  
1/2/2018Thomas WilderDirectorSell345$91.15$31,446.75View SEC Filing  
11/28/2017Adam ElsesserCEOSell10,000$103.95$1,039,500.001,121,356View SEC Filing  
11/28/2017Arani BoseInsiderSell10,927$103.96$1,135,970.92639,527View SEC Filing  
11/28/2017Sridhar KosarajuCFOSell6,026$103.83$625,679.58View SEC Filing  
11/24/2017Adam ElsesserCEOSell10,135$105.10$1,065,188.501,133,672View SEC Filing  
11/24/2017James Robert PrayInsiderSell5,088$105.26$535,562.88523,894View SEC Filing  
11/24/2017Sridhar KosarajuCFOSell4,818$105.10$506,371.80View SEC Filing  
11/22/2017Adam ElsesserCEOSell5,051$105.98$535,304.981,133,672View SEC Filing  
11/22/2017Arani BoseInsiderSell6,248$106.10$662,912.80652,118View SEC Filing  
11/22/2017Sridhar KosarajuCFOSell2,600$105.99$275,574.00View SEC Filing  
11/21/2017Bridget O'rourkeDirectorSell429$106.60$45,731.40View SEC Filing  
11/20/2017Adam ElsesserCEOSell62,862$105.15$6,609,939.301,191,887View SEC Filing  
11/20/2017Arani BoseInsiderSell47,136$105.15$4,956,350.40700,815View SEC Filing  
11/20/2017Sridhar KosarajuCFOSell21,956$105.27$2,311,308.12View SEC Filing  
11/17/2017Adam ElsesserCEOSell11,186$103.56$1,158,422.161,191,887View SEC Filing  
11/17/2017Arani BoseInsiderSell8,133$103.50$841,765.50700,815View SEC Filing  
11/17/2017Sridhar KosarajuCFOSell4,290$103.52$444,100.80View SEC Filing  
11/15/2017Adam ElsesserCEOSell24,444$105.83$2,586,908.521,231,338View SEC Filing  
11/15/2017Arani BoseInsiderSell16,452$105.89$1,742,102.28728,680View SEC Filing  
11/15/2017Sridhar KosarajuCFOSell10,900$105.89$1,154,201.00View SEC Filing  
10/5/2017Harpreet GrewalDirectorSell500$92.90$46,450.00View SEC Filing  
10/2/2017Thomas WilderDirectorSell345$90.20$31,119.00View SEC Filing  
9/29/2017Robert D EvansEVPSell20,017$90.03$1,802,130.5111,704View SEC Filing  
9/28/2017Robert D EvansEVPSell2,108$90.00$189,720.0011,704View SEC Filing  
9/27/2017Robert D EvansEVPSell1,586$90.00$142,740.0011,704View SEC Filing  
9/21/2017Robert D EvansEVPSell4,983$90.00$448,470.0011,704View SEC Filing  
9/20/2017Robert D EvansEVPSell2,859$90.00$257,310.0011,704View SEC Filing  
8/21/2017Harpreet GrewalDirectorSell4,500$82.65$371,925.00View SEC Filing  
8/9/2017Robert D EvansEVPSell10,000$85.15$851,500.0011,704View SEC Filing  
8/1/2017Daniel Donen DavisInsiderSell32,000$79.42$2,541,440.00View SEC Filing  
7/18/2017Thomas WilderDirectorSell345$86.10$29,704.50View SEC Filing  
4/24/2017Robert D EvansEVPSell10,000$85.24$852,400.0012,075View SEC Filing  
2/14/2017Robert D EvansEVPSell5,000$75.00$375,000.007,075View SEC Filing  
2/13/2017Adam ElsesserCEOSell7,700$72.21$556,017.001,241,938View SEC Filing  
2/13/2017James Robert PrayInsiderSell1,700$73.04$124,168.00543,778View SEC Filing  
2/13/2017Sridhar KosarajuCFOSell1,600$72.94$116,704.00View SEC Filing  
2/10/2017James Robert PrayInsiderSell23,900$71.08$1,698,812.00566,978View SEC Filing  
2/10/2017Sridhar KosarajuCFOSell15,500$71.49$1,108,095.00View SEC Filing  
2/9/2017Arani BoseInsiderSell22,300$70.44$1,570,812.00736,191View SEC Filing  
2/9/2017Lynn RothmanEVPSell2,700$70.20$189,540.00View SEC Filing  
2/7/2017James Robert PrayInsiderSell4,099$69.09$283,199.91575,178View SEC Filing  
2/7/2017Robert D EvansEVPSell1$70.00$70.007,075View SEC Filing  
2/6/2017Arani BoseInsiderSell17,100$70.01$1,197,171.00736,691View SEC Filing  
2/6/2017Lynn RothmanEVPSell2,886$70.41$203,203.26View SEC Filing  
2/6/2017Sridhar KosarajuCFOSell100$70.00$7,000.00View SEC Filing  
2/3/2017James Robert PrayInsiderSell15,600$70.39$1,098,084.00590,159View SEC Filing  
2/3/2017Robert D EvansEVPSell5,000$70.35$351,750.007,075View SEC Filing  
2/3/2017Sridhar KosarajuCFOSell7,800$70.56$550,368.00View SEC Filing  
2/1/2017Adam ElsesserCEOSell21,400$70.98$1,518,972.001,244,038View SEC Filing  
2/1/2017Daniel Donen DavisInsiderSell7,298$71.00$518,158.00View SEC Filing  
2/1/2017Lynn RothmanEVPSell4,414$70.99$313,349.86View SEC Filing  
1/31/2017Adam ElsesserCEOSell9,000$71.26$641,340.001,244,038View SEC Filing  
1/31/2017Daniel Donen DavisInsiderSell3,000$71.29$213,870.00View SEC Filing  
1/31/2017Lynn RothmanEVPSell1,800$71.27$128,286.00View SEC Filing  
1/30/2017Adam ElsesserCEOSell8,200$70.72$579,904.001,244,038View SEC Filing  
1/30/2017Daniel Donen DavisInsiderSell2,698$70.71$190,775.58View SEC Filing  
1/30/2017Lynn RothmanEVPSell1,700$70.79$120,343.00View SEC Filing  
1/27/2017Arani BoseInsiderSell31,500$74.12$2,334,780.00748,691View SEC Filing  
1/27/2017Lynn RothmanEVPSell7,000$74.24$519,680.00View SEC Filing  
1/26/2017Don W KassingDirectorSell3,000$74.50$223,500.002,666View SEC Filing  
11/16/2016Sridhar KosarajuCFOSell25,000$65.07$1,626,750.00View SEC Filing  
9/9/2016Adam ElsesserCEOSell57,200$71.07$4,065,204.001,249,838View SEC Filing  
9/6/2016Arani BoseInsiderSell61,000$70.72$4,313,920.00742,891View SEC Filing  
9/2/2016Robert D EvansEVPSell3,100$70.10$217,310.002,538View SEC Filing  
8/31/2016Adam ElsesserCEOSell26,000$71.15$1,849,900.001,244,838View SEC Filing  
8/31/2016Robert D EvansEVPSell5,300$71.17$377,201.002,538View SEC Filing  
8/26/2016Adam ElsesserCEOSell26,800$71.06$1,904,408.001,244,638View SEC Filing  
8/26/2016Robert D EvansEVPSell5,300$71.03$376,459.002,538View SEC Filing  
8/24/2016Adam ElsesserCEOSell29,000$72.95$2,115,550.001,245,938View SEC Filing  
8/24/2016Robert D EvansEVPSell6,300$73.00$459,900.002,538View SEC Filing  
5/23/2016Robert D EvansEVPSell5,000$50.52$252,600.002,538View SEC Filing  
5/19/2016Don W KassingDirectorSell3,000$48.63$145,890.004,000View SEC Filing  
5/19/2016Robert D EvansEVPBuy1,538$25.50$39,219.002,538View SEC Filing  
5/16/2016James Robert PrayInsiderSell32,500$48.51$1,576,575.00631,770View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Penumbra (NYSE PEN) News Headlines

Source:
DateHeadline
Penumbra, Inc. Schedules First Quarter 2018 Earnings Release and Conference Call for May 8, 2018Penumbra, Inc. Schedules First Quarter 2018 Earnings Release and Conference Call for May 8, 2018
finance.yahoo.com - April 18 at 4:54 PM
Penumbra (PEN) versus Its Competitors Financial AnalysisPenumbra (PEN) versus Its Competitors Financial Analysis
www.americanbankingnews.com - April 16 at 7:07 PM
Penumbra (PEN) Lowered to "Hold" at BidaskClubPenumbra (PEN) Lowered to "Hold" at BidaskClub
www.americanbankingnews.com - April 16 at 5:24 PM
Penumbra Inc (PEN) Given Average Recommendation of "Buy" by BrokeragesPenumbra Inc (PEN) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - April 12 at 8:49 AM
Penumbra Inc (PEN) Expected to Announce Quarterly Sales of $92.57 MillionPenumbra Inc (PEN) Expected to Announce Quarterly Sales of $92.57 Million
www.americanbankingnews.com - April 12 at 1:48 AM
 Brokerages Expect Penumbra Inc (PEN) Will Post Earnings of -$0.02 Per Share Brokerages Expect Penumbra Inc (PEN) Will Post Earnings of -$0.02 Per Share
www.americanbankingnews.com - April 10 at 11:21 PM
Penumbras (PEN) Buy Rating Reiterated at Canaccord GenuityPenumbra's (PEN) Buy Rating Reiterated at Canaccord Genuity
www.americanbankingnews.com - April 5 at 1:57 PM
Penumbra (PEN) Research Coverage Started at Goldman SachsPenumbra (PEN) Research Coverage Started at Goldman Sachs
www.americanbankingnews.com - April 4 at 8:04 AM
Penumbra (PEN) PT Raised to $117.00Penumbra (PEN) PT Raised to $117.00
www.americanbankingnews.com - April 1 at 9:11 AM
Penumbra (PEN) Stock Rating Lowered by Zacks Investment ResearchPenumbra (PEN) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - March 29 at 5:48 PM
$92.57 Million in Sales Expected for Penumbra Inc (PEN) This Quarter$92.57 Million in Sales Expected for Penumbra Inc (PEN) This Quarter
www.americanbankingnews.com - March 26 at 1:50 AM
 Analysts Anticipate Penumbra Inc (PEN) Will Announce Earnings of -$0.02 Per Share Analysts Anticipate Penumbra Inc (PEN) Will Announce Earnings of -$0.02 Per Share
www.americanbankingnews.com - March 24 at 11:16 PM
Head-To-Head Contrast: Penumbra (PEN) vs. Its PeersHead-To-Head Contrast: Penumbra (PEN) vs. Its Peers
www.americanbankingnews.com - March 22 at 3:24 PM
With A -68.56% Earnings Drop, Did Penumbra Inc (NYSE:PEN) Really Underperform?With A -68.56% Earnings Drop, Did Penumbra Inc (NYSE:PEN) Really Underperform?
finance.yahoo.com - March 20 at 9:27 AM
Insider Selling: Penumbra Inc (PEN) EVP Sells 6,000 Shares of StockInsider Selling: Penumbra Inc (PEN) EVP Sells 6,000 Shares of Stock
www.americanbankingnews.com - March 19 at 7:28 PM
Wells Fargo Boosts Penumbra (PEN) Price Target to $138.00Wells Fargo Boosts Penumbra (PEN) Price Target to $138.00
www.americanbankingnews.com - March 18 at 11:14 AM
Penumbra Inc (PEN) Given Average Recommendation of "Hold" by BrokeragesPenumbra Inc (PEN) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - March 18 at 8:54 AM
Robert D. Evans Sells 10,000 Shares of Penumbra Inc (PEN) StockRobert D. Evans Sells 10,000 Shares of Penumbra Inc (PEN) Stock
www.americanbankingnews.com - March 14 at 7:12 PM
What Should We Expect From Penumbra Inc’s (NYSE:PEN) Earnings In The Year Ahead?What Should We Expect From Penumbra Inc’s (NYSE:PEN) Earnings In The Year Ahead?
finance.yahoo.com - March 12 at 5:43 PM
Form 4 Penumbra Inc For: Mar 05 Filed by: Rothman LynnForm 4 Penumbra Inc For: Mar 05 Filed by: Rothman Lynn
www.streetinsider.com - March 8 at 9:32 AM
Lynn Rothman Sells 3,727 Shares of Penumbra Inc (PEN) StockLynn Rothman Sells 3,727 Shares of Penumbra Inc (PEN) Stock
www.americanbankingnews.com - March 8 at 12:30 AM
-$0.02 Earnings Per Share Expected for Penumbra Inc (PEN) This Quarter-$0.02 Earnings Per Share Expected for Penumbra Inc (PEN) This Quarter
www.americanbankingnews.com - March 7 at 5:29 PM
Penumbra Inc (PEN) Shares Sold by Next Century Growth Investors LLCPenumbra Inc (PEN) Shares Sold by Next Century Growth Investors LLC
www.americanbankingnews.com - March 3 at 3:54 PM
Penumbra Inc (PEN) Stake Increased by OppenheimerFunds Inc.Penumbra Inc (PEN) Stake Increased by OppenheimerFunds Inc.
www.americanbankingnews.com - March 3 at 10:34 AM
Insider Selling: Penumbra Inc (PEN) EVP Sells 2,273 Shares of StockInsider Selling: Penumbra Inc (PEN) EVP Sells 2,273 Shares of Stock
www.americanbankingnews.com - March 2 at 9:20 PM
Swiss National Bank Raises Holdings in Penumbra Inc (PEN)Swiss National Bank Raises Holdings in Penumbra Inc (PEN)
www.americanbankingnews.com - March 2 at 7:32 PM
Penumbra Inc Expected to Post FY2018 Earnings of $0.10 Per Share (PEN)Penumbra Inc Expected to Post FY2018 Earnings of $0.10 Per Share (PEN)
www.americanbankingnews.com - March 2 at 2:10 PM
EAM Investors LLC Has $1.83 Million Stake in Penumbra Inc (PEN)EAM Investors LLC Has $1.83 Million Stake in Penumbra Inc (PEN)
www.americanbankingnews.com - March 2 at 1:05 PM
Penumbra Inc (PEN) to Post Q3 2018 Earnings of $0.04 Per Share, William Blair ForecastsPenumbra Inc (PEN) to Post Q3 2018 Earnings of $0.04 Per Share, William Blair Forecasts
www.americanbankingnews.com - March 1 at 10:21 AM
Penumbra Inc (PEN) Shares Sold by First Republic Investment Management Inc.Penumbra Inc (PEN) Shares Sold by First Republic Investment Management Inc.
www.americanbankingnews.com - March 1 at 9:12 AM
Penumbra, Inc. (PEN) Reports Q4 EPS of $0.25, Beats on Revenues; Offers FY18 Revenue Guidance Above EstimatesPenumbra, Inc. (PEN) Reports Q4 EPS of $0.25, Beats on Revenues; Offers FY18 Revenue Guidance Above Estimates
www.streetinsider.com - March 1 at 8:59 AM
Canaccord Genuity Reaffirms "Buy" Rating for Penumbra (PEN)Canaccord Genuity Reaffirms "Buy" Rating for Penumbra (PEN)
www.americanbankingnews.com - February 28 at 11:22 PM
BMO Capital Markets Raises Penumbra (PEN) Price Target to $115.00BMO Capital Markets Raises Penumbra (PEN) Price Target to $115.00
www.americanbankingnews.com - February 28 at 5:14 PM
Wells Fargo & Co Increases Penumbra (PEN) Price Target to $125.00Wells Fargo & Co Increases Penumbra (PEN) Price Target to $125.00
www.americanbankingnews.com - February 28 at 4:27 PM
Penumbra Inc (PEN) Holdings Trimmed by Champlain Investment Partners LLCPenumbra Inc (PEN) Holdings Trimmed by Champlain Investment Partners LLC
www.americanbankingnews.com - February 28 at 12:58 PM
Penumbra beats Street 4Q forecastsPenumbra beats Street 4Q forecasts
finance.yahoo.com - February 28 at 9:09 AM
Penumbra (PEN) Posts Earnings in Q4, Revenues Top EstimatesPenumbra (PEN) Posts Earnings in Q4, Revenues Top Estimates
finance.yahoo.com - February 28 at 9:09 AM
Penumbra Inc (PEN) Shares Bought by Schwab Charles Investment Management Inc.Penumbra Inc (PEN) Shares Bought by Schwab Charles Investment Management Inc.
www.americanbankingnews.com - February 28 at 5:45 AM
Penumbra, Inc. to Host Earnings CallPenumbra, Inc. to Host Earnings Call
finance.yahoo.com - February 27 at 5:13 PM
Penumbra, Inc. Reports Fourth Quarter and Full Year 2017 Financial ResultsPenumbra, Inc. Reports Fourth Quarter and Full Year 2017 Financial Results
finance.yahoo.com - February 27 at 5:13 PM
Carillon Tower Advisers Inc. Acquires New Position in Penumbra Inc (PEN)Carillon Tower Advisers Inc. Acquires New Position in Penumbra Inc (PEN)
www.americanbankingnews.com - February 27 at 5:32 AM
Is a Surprise Coming for Penumbra (PEN) This Earnings Season?Is a Surprise Coming for Penumbra (PEN) This Earnings Season?
www.zacks.com - February 26 at 9:08 AM
Is Penumbra Inc (NYSE:PEN) An Industry Laggard Or Leader?Is Penumbra Inc (NYSE:PEN) An Industry Laggard Or Leader?
finance.yahoo.com - February 23 at 9:10 AM
William Blair Comments on Penumbra Incs FY2017 Earnings (PEN)William Blair Comments on Penumbra Inc's FY2017 Earnings (PEN)
www.americanbankingnews.com - February 23 at 8:24 AM
Penumbra Has Challenged The Paradigm Of Stroke Treatment; William Blair Initiates At OutperformPenumbra Has Challenged The 'Paradigm' Of Stroke Treatment; William Blair Initiates At Outperform
finance.yahoo.com - February 22 at 9:06 AM
Afghan tradition helps strangers become friends over dinnerAfghan tradition helps strangers become friends over dinner
www.msn.com - February 21 at 4:50 PM
Penumbra (PEN) Research Coverage Started at William BlairPenumbra (PEN) Research Coverage Started at William Blair
www.americanbankingnews.com - February 21 at 10:58 AM
Key Factors to Influence Penumbra's (PEN) Earnings in Q4Key Factors to Influence Penumbra's (PEN) Earnings in Q4
finance.yahoo.com - February 21 at 9:15 AM
Penumbra Inc (PEN) Expected to Post Earnings of -$0.01 Per SharePenumbra Inc (PEN) Expected to Post Earnings of -$0.01 Per Share
www.americanbankingnews.com - February 19 at 1:16 AM
Should You Buy Penumbra Inc (NYSE:PEN) At $93.6?Should You Buy Penumbra Inc (NYSE:PEN) At $93.6?
finance.yahoo.com - February 15 at 4:44 PM

SEC Filings

Penumbra (NYSE:PEN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Penumbra (NYSE:PEN) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Penumbra (NYSE PEN) Stock Chart for Saturday, April, 21, 2018

Loading chart…

This page was last updated on 4/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.